Clinical trials
Transition clinical trials
Below are recruiting transition clinical trials, each written for real people, not researchers. We’re tracking 189 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05733832Recruiting
Transitional care after hospital discharge for serious liver disease
This trial tests an extra support program after you leave the hospital to help people with advanced liver disease avoid complications and stay on track. It may help by providing structured follow-up soon after discharge.
Chicago, IllinoisAges 18 years+ - NCT06093906Recruiting
Positive processes and transition to health (PATH) study
This study tests a new therapy that may help people recover after a stressful life event. Over about 6 weeks, you'll work with a coach to retrain your brain's patterns and feel more in control again, as well as reconnect with positive activities.
Newark, DelawareAges 18–65 - NCT06051058Recruiting
App for managing health after hospital discharge
This study tests a smartphone app designed to help people with multiple health conditions manage their care after leaving the hospital. It may help you feel more supported and avoid confusion during the transition from hospital to home.
Boston, MassachusettsAges 55 years+ - NCT05995678Recruiting
STEP Home Workshop for veterans adjusting to civilian life
This pilot study tests a workshop called STEP Home to help veterans who recently left the military and are having trouble readjusting. The goal is to improve their transition and reduce suicide risk.
Boston, MassachusettsAges 18–65 - NCT05991115Recruiting
Hospital to home study for children with asthma
This study helps families whose child is in the hospital for asthma. It aims to make the transition home smoother and reduce asthma-related health differences.
Washington D.C., District of ColumbiaAges 4–12 - NCT05897125Enrolling by invitation
Telehealth education to help people with COPD after a hospital stay
This study tests whether a telehealth (video/phone) education program can help people with COPD better manage their health after a hospital flare-up. It may reduce the chance of needing to return to the hospital soon after discharge.
Chicago, IllinoisAges 18 years+ - NCT05874921Recruiting
Registry for adults with UTUC treated with Jelmyto
This registry collects information about adults with upper tract urothelial cancer (UTUC) who received Jelmyto after it was approved. It helps doctors understand outcomes and real-world experience with Jelmyto.
Santa Monica, CaliforniaAges 18 years+ - NCT05865652Recruiting
7T brain scan study for teens at risk of psychosis
This trial tests how the brain’s cell membranes and energy use look in teens who are at high risk of developing psychosis. It compares them with healthy teens to better understand early brain changes that might help future care.
PoitiersAges 15–25 - NCT05806645Recruiting
Digital tools to guide recovery after a kidney injury
This study uses personalized risk information and digital tools to help people plan safe transitions after a recent hospital kidney injury. The goal is to better guide next steps and reduce the chance of future kidney problems.
Calgary, AlbertaAges 18 years+ - NCT05520983Enrolling by invitation
Behavior program study for teens with learning or thinking differences
This study is testing a “behavioral health” treatment plan designed for teens who have intellectual and/or developmental disabilities. It may help identify which treatment approach works best for different youth needs.
Chicago, IllinoisAges 13–20 - NCT05084937Enrolling by invitation
Study on celiac disease from teens into adulthood
This trial looks at how people with celiac disease transition from childhood into adulthood, using questionnaires. It also includes people without celiac disease for comparison, to help researchers understand similarities and differences during these teen years.
KuopioAges 13–19 - NCT07625527RecruitingPhase 2
Stopping immunotherapy after bladder cancer disappears
This trial tests whether it's safe to stop immunotherapy once bladder cancer is no longer visible, instead of continuing it for a longer time. It aims to find out if stopping treatment early can reduce side effects while keeping the cancer from coming back.
TianjinAges 18 years+ - NCT04463160Recruiting
Study to learn why prediabetes becomes diabetes
This study looks for factors that make prediabetes turn into diabetes in adults in Reunion. You may be asked health questions by phone, and your results may help improve how prediabetes is prevented from progressing.
Saint-PierreAges 25–70 - NCT04028219Recruiting
Study for people transitioning gender-affirming care
This study looks at people who are preparing to start gender-affirming hormone treatment. It may help researchers understand what support is needed before hormones begin.
Frankfurt am Main, HesseAges 18 years+ - NCT06309160Recruiting
Helping students with autism transition to adulthood
This study tests a program to help students with autism transition to adult life. It is for students, caregivers, teachers, and job specialists who want to improve these important life changes.
Muncie, IndianaAges 16–99 - NCT07816445Recruiting
Parenting conflict program for separating or divorcing parents
This study tests a program for parents who are separating or divorcing. It aims to help reduce conflict between parents, which could be helpful for them and their children.
Tempe, ArizonaAges 88 years+ - NCT07815249Recruiting
Speech therapy for children with rare genetic conditions and speech apraxia
This trial tests a speech therapy program for children with rare genetic conditions who also have childhood apraxia of speech, a disorder where the brain has trouble planning the movements needed for speech. The therapy is intensive—three sessions a week for four weeks—and may help improve your child's ability to speak clearly.
Melbourne, VictoriaAges 3–16 - NCT07759804RecruitingPhase 4
Switching from selexipag to inhaled treprostinil for pulmonary arterial hypertension
This study tests whether switching from the oral medicine selexipag to an inhaled medicine called treprostinil can improve symptoms or side effects in people with pulmonary arterial hypertension (PAH). It may be an option if you are not getting enough benefit or are having trouble tolerating selexipag.
Columbus, GeorgiaAges 18–80 - NCT06258369Recruiting
How people with hip arthritis start walking
This study looks at how people with hip arthritis begin to walk and shift their weight from one leg to the other. It aims to understand movement changes before hip replacement surgery.
LilleAges 18 years+ - NCT07750288Recruiting
Studying shortness of breath in children with acute respiratory distress
This study looks at how shortness of breath (dyspnea) relates to the progression of pediatric acute respiratory distress syndrome (PARDS), a severe lung condition in children. It aims to understand breathing difficulties better to improve care.
SantiagoAges 1 month–18 years - NCT07734363Recruiting
How Cravings Affect Addiction Severity Over Time
This trial is a longitudinal study that tracks how cravings (strong urges to use) affect a person's addiction over time. It may help researchers understand how cravings lead to more severe addiction, which could improve future treatments.
BordeauxAges 18 years+ - NCT07725796RecruitingPhase 1
Study of UGN-501 for recurrent bladder cancer
This study tests an experimental medicine called UGN-501 given directly into the bladder. It is for people whose bladder cancer has come back despite previous treatments, such as BCG therapy. The goal is to find the best dose and see how safe and effective it is.
Queen Creek, ArizonaAges 18 years+ - NCT07717151Recruiting
Preventing long-term pain after surgery for chronic opioid users
This trial tests a method to prevent chronic pain after surgery in people who already take opioids regularly. It may help reduce long-term pain and improve recovery.
AmiensAges 18 years+ - NCT07663240Enrolling by invitation
Program to help women with epilepsy reduce ER visits
This study is for Black or Hispanic women with epilepsy who often go to the emergency room for seizures. It aims to help reduce ER visits by connecting you with better follow-up care and support.
Atlanta, GeorgiaAges 18 years+
Hear when a new Transition trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for transition?
- Yes. Clin2 currently lists 189 recruiting transition studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a transition trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a transition trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.